Feb 13, 2020

Starpharma collects milestone payment from AstraZeneca

Starpharma collects milestone payment from AstraZeneca

Biotech Dispatch reported that AstraZeneca has paid Starpharma a $4.5 million milestone payment following the successful dosing of the first patient in the phase 1 clinical trial of AZD0466. The article mentioned the long standing partnership between the two companies which is focused on using Starpharma’s DEP® drug delivery platform to enhance AstraZeneca’s medicines.

To read the full article click here

 This contains certain forward-looking statements.